INTERNATIONAL PATENT: CHONG KUN DANG PHARMACEUTICAL CORP. FILES APPLICATION FOR "PHARMACEUTICAL FORMULATION COMPRISING OSIMERTINIB OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF"

GENEVA, May 5 -- CHONG KUN DANG PHARMACEUTICAL CORP. (8, Chungjeong-roSeodaemun-guSeoul 03742) filed a patent application (PCT/KR2025/017027) for "PHARMACEUTICAL FORMULATION COMPRISING OSIMERTINIB OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF" on Oct 24, 2025. With publication no. WO/2026/089548, the details related to the patent application was published on Apr 30, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KIM, Junheon (315-20 Dongbaekjukjeon-daero, Giheung-guYongin-siGyeonggi-do 16995), HAN, Sungkyun (315-20 Dongbaekjukjeon-daero, Giheung-guYongin-siGyeonggi-do 16995)

Abstract: The p...